14-day Premium Trial Subscription Sign Up For FreeGet Free

AEterna Zentaris Inc. Stock Forecast NASDAQ:AEZS

$0.33 (-6.41%)

Volume: 1M

Closed: Jan 21, 2022

Hollow Logo Score: -4.059

AEterna Zentaris Inc. Stock Forecast

$0.33 (-6.41%)

Volume: 1M

Closed: Jan 21, 2022

Score Hollow Logo -4.059

AEterna Zentaris Inc. Stock Price (Quote) NASDAQ:AEZS

$0.33 ( -6.41% ) Friday, 21st Jan 2022

Range Low Price High Price Comment
30 days $0.32 $0.43 Friday, 21st Jan 2022 AEZS stock ended at $0.33. This is 6.41% less than the trading day before Thursday, 20th Jan 2022. During the day the stock fluctuated 5.58% from a day low at $0.32 to a day high of $0.34.
90 days $0.32 $0.68
52 weeks $0.32 $3.62

Historical AEterna Zentaris Inc. prices

Date Open High Low Close Volume
2022-01-21 $0.34 $0.34 $0.32 $0.33 1 211 424
2022-01-20 $0.34 $0.36 $0.34 $0.35 886 892
2022-01-19 $0.35 $0.35 $0.33 $0.34 856 714
2022-01-18 $0.36 $0.36 $0.33 $0.34 1 429 035
2022-01-14 $0.36 $0.37 $0.35 $0.36 785 207
2022-01-13 $0.37 $0.38 $0.36 $0.36 985 949
2022-01-12 $0.37 $0.38 $0.36 $0.37 931 752
2022-01-11 $0.36 $0.37 $0.35 $0.36 674 709
2022-01-10 $0.37 $0.37 $0.35 $0.36 770 377
2022-01-07 $0.36 $0.38 $0.35 $0.37 514 145
2022-01-06 $0.36 $0.38 $0.35 $0.36 1 155 300
2022-01-05 $0.38 $0.39 $0.36 $0.36 1 065 440
2022-01-04 $0.39 $0.40 $0.38 $0.38 1 330 272
2022-01-03 $0.36 $0.40 $0.36 $0.39 1 778 808
2021-12-31 $0.38 $0.38 $0.35 $0.36 2 856 484
2021-12-30 $0.37 $0.39 $0.36 $0.37 1 926 885
2021-12-29 $0.39 $0.39 $0.36 $0.37 3 114 353
2021-12-28 $0.39 $0.40 $0.38 $0.38 2 034 026
2021-12-27 $0.42 $0.43 $0.40 $0.40 1 197 081
2021-12-23 $0.42 $0.43 $0.41 $0.42 640 917
2021-12-22 $0.41 $0.43 $0.41 $0.42 886 075
2021-12-21 $0.40 $0.41 $0.40 $0.41 892 688
2021-12-20 $0.41 $0.42 $0.39 $0.40 674 820
2021-12-17 $0.42 $0.43 $0.40 $0.42 794 971
2021-12-16 $0.43 $0.44 $0.41 $0.41 510 625
2021-12-15 $0.42 $0.43 $0.40 $0.41 922 442
2021-12-14 $0.42 $0.44 $0.41 $0.42 804 544
2021-12-13 $0.43 $0.45 $0.42 $0.44 502 607
2021-12-10 $0.46 $0.46 $0.42 $0.43 715 073
2021-12-09 $0.46 $0.49 $0.45 $0.45 780 740
2021-12-08 $0.45 $0.46 $0.44 $0.46 462 335
2021-12-07 $0.44 $0.47 $0.43 $0.45 779 230
2021-12-06 $0.40 $0.44 $0.38 $0.44 1 656 073
2021-12-03 $0.44 $0.44 $0.40 $0.40 2 209 885
2021-12-02 $0.44 $0.45 $0.41 $0.43 1 209 303
2021-12-01 $0.47 $0.50 $0.45 $0.45 1 035 285
2021-11-30 $0.48 $0.49 $0.46 $0.48 719 084
2021-11-29 $0.49 $0.50 $0.47 $0.48 1 189 754
2021-11-26 $0.48 $0.51 $0.46 $0.49 1 388 540
2021-11-24 $0.48 $0.49 $0.44 $0.49 1 170 300
2021-11-23 $0.47 $0.49 $0.47 $0.47 746 363
2021-11-22 $0.51 $0.51 $0.46 $0.48 1 631 697
2021-11-19 $0.49 $0.52 $0.49 $0.51 1 049 900
2021-11-18 $0.52 $0.53 $0.49 $0.50 1 957 363
2021-11-17 $0.53 $0.54 $0.52 $0.52 1 147 800
2021-11-16 $0.55 $0.55 $0.53 $0.53 1 607 130
2021-11-15 $0.56 $0.57 $0.55 $0.55 1 069 022
2021-11-12 $0.57 $0.57 $0.55 $0.56 1 131 897
2021-11-11 $0.55 $0.57 $0.55 $0.56 984 806
2021-11-10 $0.59 $0.59 $0.54 $0.55 2 830 924

About AEterna Zentaris Inc.

AEterna Zentaris Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company’s product pipeline includes Zoptrex, which is in Phase III clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer, as well as completed Phase II clinical trial for the tr... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT